OR WAIT null SECS
April 15, 2020
ISPE’s Facility of the Year Awards for 2020 go to bio/pharma companies in eight award categories, including two winners in the new Social Impact category.
April 02, 2020
Risk levels should be considered when designing containment for pharmaceutical tableting equipment to enhance operator safety.
Whether refitting existing spaces or building new, the need for quick build times, flexibility, and production efficiency is driving trends in bio/pharma facility construction.
March 24, 2020
Thermo Fisher is focused on investing to expand three specific areas of demand: biologics, cell and gene therapy, and drug product development and commercial capabilities.
March 18, 2020
Technologies and methods for new and refurbished manufacturing facility construction expand capacity for new modalities and to ease shortages.
March 11, 2020
Through the agreement, Bora will obtain ownership of the entire Mississauga site, including all facilities, under the proper regulatory clearances.
March 02, 2020
The growing interest in developing cell and gene therapies has prompted industry investment to grow manufacturing capacity.
The last year has seen intense investment activity into raising cell and gene therapy manufacturing capacity.
Energy and water waste can be improved with new technologies, and sustainability can be considered in the design of new facilities.
February 27, 2020
The expansion gives the company diversified capacity running cell production lines featuring Sartorius-brand 2000-L disposable bioreactors and now GE-brand 2000-L single-use bioreactors.